|
|
|
|
|
Unique capability
to analyse every aspect of the pharmaceutical
marketplace
|
|
|
|
 
|
|
|
IMS Lifecycle is a comprehensive
source of drug information covering three critical stages
of the product lifecycle; R&D activity, product launch
and patent status.
|
|
|
|
|
IMS Lifecycle brings together
three IMS databases: R&D
Focus, New
Product Focus and Patent
Focus under one common interface. It contains:
|
|
11,000 profiles of
drugs in R&D
|
|
|
1,200 drug patent
families
|
|
|
100,000 new drug launches
|
This allows investigation of
a product across all aspects of its development. It will be
vital in producing:
|
|
Competitor company
and product profiles
|
|
|
Benchmarking reports
on your current and planned strategy
|
|
|
Candidates for new
business opportunities
|
|
Available
on CD ROM, or on the web |
|
|
|
|
|
A complete worldwide picture
of the R&D, patent and launch status of any product within
a given therapy area.
It has applications for:
|
|
Strategic planning
|
|
|
Licensing
|
|
|
Investment decisions
|
|
|
New Business development
|
|
|
Competitive intelligence
|
|
|
|
|
|
|
For
prices contact IMS Health.
|
Available on CD
ROM or web. Other licences available
Visit
IMS
LifeCycle microsite
Request
further information |
|
|
|
